← Back to Search

Behavioral Intervention

Nurse-Led Phone Support for Heart Failure (CARE-HF Trial)

N/A
Recruiting
Led By Lucinda J Graven, PhD
Research Sponsored by Florida State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosed with heart failure (reduced or preserved ejection fraction)
Age 18 years of age or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18-months
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a phone-based program, run by nurses, to improve physical and mental health in Veterans with heart failure. It's done in the US and monitored for 18 months.

Who is the study for?
This trial is for US Veterans aged 18 or older who have been diagnosed with heart failure, regardless of the type. Participants must be able to read, speak, and understand English and have reliable telephone access. Those with a history of cognitive dysfunction cannot join.
What is being tested?
The study tests a tailored telehealth program called Care-HF designed for veterans with heart failure. It involves working with a nurse over the phone for 12 weeks, including eight sessions aimed at improving physical and mental health.
What are the potential side effects?
Since this intervention is non-medical and involves only telephone-based problem-solving sessions, there are no direct medical side effects associated with drugs or procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with heart failure.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 18-months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Anxiety
Depression
Heart Failure Self-care
+1 more
Secondary study objectives
Coping
Health Related Quality of Life
Healthcare Utilization
+2 more
Other study objectives
Problem-Solving
Social Support

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: CARE-HFExperimental Treatment1 Intervention
The problem-solving intervention will be led by a registered nurse. Participants will receive a program manual containing examples of common HF-related problems experienced by heart failure patients and suggested management strategies, with some strategies tailored to the rural sociocultural context. The nurse will lead participants in a card sorting task intended to help participants prioritize current HF-related problems and will guide participants in developing management strategies for the highest priority problem(s). Participants will utilize these strategies until the next session at which time the nurse will guide participants in evaluating the effectiveness of chosen strategies. The iterative process then begins again. Participants will receive 7 follow-up telephone sessions with the nurse. In the intervention, the nurse will focus on problems related to self-care, disease management, mental health, and quality of life, including those specific to the rural population.

Find a Location

Who is running the clinical trial?

Florida State UniversityLead Sponsor
224 Previous Clinical Trials
36,541 Total Patients Enrolled
US Department of Veterans AffairsFED
875 Previous Clinical Trials
498,321 Total Patients Enrolled
Lucinda J Graven, PhDPrincipal InvestigatorFlorida State University College of Nursing

Media Library

Care-HF (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05839067 — N/A
Congestive Heart Failure Research Study Groups: CARE-HF
Congestive Heart Failure Clinical Trial 2023: Care-HF Highlights & Side Effects. Trial Name: NCT05839067 — N/A
Care-HF (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05839067 — N/A
~33 spots leftby Sep 2025